ATLAS: A phase 3 trial evaluating the efficacy of apalutamide (ARN-509) in patients with high-risk localized or locally advanced prostate cancer receiving primary radiation therapy

被引：2
|
作者：
Bossi, A. [1 ]
Dearnaley, D. [2 ,3 ]
McKenzie, M. [4 ]
Baskin-Bey, E. [5 ]
Tyler, R. [5 ]
Tombal, B. [6 ]
Freedland, S. J. [7 ]
Roach, M., III [8 ]
Widmark, A. [9 ]
Dicker, A. P. [10 ]
Wiegel, T. [11 ]
Shore, N. [12 ]
Smith, M. [13 ,14 ]
Yu, M. [5 ]
Kheoh, T. [15 ]
Thomas, S. [16 ]
Sandler, H. M. [17 ]
机构：
[1] Inst Gustave Roussy, Radiat Oncol, Villejuif, France
[2] Inst Canc Res, Acad Radiotherapy, London, England
[3] Royal Marsden Hosp, London, England
[4] British Columbia Canc Agcy, Med Oncol, Vancouver, BC, Canada
[5] Janssen Res & Dev, WC Clin Oncol, Los Angeles, CA USA
[6] Clin Univ St Luc, Urol, Brussels, Belgium
[7] Cedars Sinai Med Ctr, Surg, Los Angeles, CA 90048 USA
[8] Univ Calif San Francisco, Radiat Oncol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[9] Umea Univ, Radiat Sci, Umea, Sweden
[10] Thomas Jefferson Univ, Radiat Oncol, Philadelphia, PA 19107 USA
[11] Ulm Med Univ, Radiat Oncol, Ulm, Germany
[12] Carolina Urol Res Ctr, Urol, Myrtle Beach, SC USA
[13] Massachusetts Gen Hosp, Ctr Canc, Hematol Oncol, Boston, MA USA
[14] Harvard Med Sch, Boston, MA USA
[15] Janssen Res & Dev, Clin Biostat, San Diego, CA USA
[16] Janssen Pharmaceut, Oncol Translat Res, Spring House, PA USA
[17] Cedars Sinai Med Ctr, Radiat Oncol, Los Angeles, CA 90048 USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw372.52
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
769TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Re: Combined Androgen Deprivation Therapy and Radiation Therapy for Locally Advanced Prostate Cancer: A Randomised, Phase 3 Trial
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2012, 188 (03): : 810 - 810
  • [32] Re: Combined Androgen Deprivation Therapy and Radiation Therapy for Locally Advanced Prostate Cancer: A Randomised, Phase 3 Trial
    Saad, Fred
    EUROPEAN UROLOGY, 2012, 62 (05) : 932 - 933
  • [33] Randomized phase II trial of neoadjuvant androgen deprivation therapy plus abiraterone and apalutamide for patients with high-risk localized prostate cancer: Pathologic response and PSMA imaging correlates.
    Bastos, Diogo Assed
    Coelho, Rafael
    Cardili, Leonardo
    Galiza, Felipe
    Ilario, Eder Nisi
    Viana, Ublio
    Murta, Claudio Bovolenta
    Guglielmetti, Giuliano
    Cordeiro, Mauricio
    Pontes, Jose, Jr.
    Muniz, David Queiroz Borges
    Silva, Jamile Almeida
    Mota, Jose Mauricio
    De Freitas, Guilherme Fialho
    Leite, Katia Ramos Moreira
    Buchpiguel, Carlos Alberto
    Nahas, William Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer
    Parikh, Neil R.
    Kishan, Amar U.
    Kane, Nathanael
    Diaz-Perez, Silvia
    Ganapathy, Ekambaram
    Nazarian, Ramin
    Felix, Carol
    Mathis, Colleen
    Bradley, Margaret
    Sachdeva, Ankush
    Wyatt, Bashir
    Basehart, Vince
    Zomorodian, Nazy
    Lin, Lin
    King, Christopher R.
    Kupelian, Patrick A.
    Rettig, Matthew B.
    Steinberg, Michael L.
    Cao, Minsong
    Knudsen, Beatrice S.
    Elashoff, David
    Schaue, Dorthe
    Reiter, Robert E.
    Nickols, Nicholas G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (04): : 930 - 935
  • [35] Primary Radiation Therapy Is Equivalent to Robotic Prostatectomy Plus Adjuvant Radiation Therapy in Patients With High-Risk Prostate Cancer
    Arora, S.
    Singh, P.
    Christos, P.
    Wernicke, A.
    Nori, D.
    Chao, K.
    Parashar, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S388 - S389
  • [36] Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
    Chin, Joseph L.
    Bauman, Glenn S.
    EUROPEAN UROLOGY, 2020, 78 (05) : 765 - 766
  • [37] Randomized Phase 3 Trial of Adjuvant Androgen Deprivation in Combination With High-Dose Conformal Radiation Therapy in Intermediate- and High-Risk Localized Prostate Cancer
    Zapatero, A.
    Guerrero, A.
    Maldonado, J.
    Alvarez, A.
    Gonzalez San Segundo, C.
    Cabeza Rodriguez, M.
    Macias, V.
    Pedro-Olive, A.
    Casas, F.
    Boladeras, A.
    Martin de Vidales, C.
    Vazquez de la Torre, M.
    Calvo, F. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S1 - S1
  • [38] A Randomized Feasibility Trial of Stereotactic Prostate Radiation Therapy With or Without Elective Nodal Irradiation in High-Risk Localized Prostate Cancer (SPORT Trial)
    Houlihan, Orla A.
    Redmond, Kelly
    Fairmichael, Ciaran
    Lyons, Ciara A.
    McGarry, Conor K.
    Mitchell, Darren
    Cole, Aidan
    O'Connor, John
    McMahon, Stephen
    Irvine, Denise
    Hyland, Wendy
    Hanna, Michael
    Prise, Kevin M.
    Hounsell, Alan R.
    O'Sullivan, Joe M.
    Jain, Suneil
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (03): : 594 - 609
  • [39] CLINICAL INVESTIGATION Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate-to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial
    Yasar, Binnaz
    Suh, Yae-Eun
    Chapman, Ewan
    Nicholls, Luke
    Henderson, Daniel
    Jones, Caroline
    Morrison, Kirsty
    Wells, Emma
    Henderson, Julia
    Meehan, Carole
    Sohaib, Aslam
    Taylor, Helen
    Tree, Alison
    van As, Nicholas
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (01): : 49 - 58
  • [40] Current Trends for the Use of Androgen Deprivation Therapy in Conjunction With Radiotherapy for Patients With Unfavorable Intermediate-Risk, High-Risk, Localized, and Locally Advanced Prostate Cancer
    Roach, Mack, III
    CANCER, 2014, 120 (11) : 1620 - 1629
12345